XML 20 R4.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2015
Dec. 31, 2014
Current Assets:    
Cash and cash equivalents $ 1,459.3 $ 1,083.3
Short-term investments 164.6 612.5
Accounts receivable, less allowance for doubtful accounts 1,446.5 912.1
Inventories 2,254.1 1,193.3
Prepaid expenses and other current assets 538.4 317.2
Deferred income taxes   194.9
Total Current Assets 5,862.9 4,313.3
Property, plant and equipment, net 2,062.6 1,285.3
Goodwill 9,934.2 2,514.2
Intangible assets, net 8,746.3 603.5
Other assets 613.5 941.7
Total Assets 27,219.5 9,658.0
Current Liabilities:    
Accounts payable 284.8 145.2
Income taxes 147.2 80.3
Other current liabilities 1,185.9 798.5
Total Current Liabilities 1,617.9 1,024.0
Deferred income taxes 3,150.2 45.9
Other long-term liabilities 1,005.7 610.9
Long-term debt 11,556.3 1,425.5
Total Liabilities $ 17,330.1 $ 3,106.3
Commitments and Contingencies (Note 20)
Stockholders' Equity:    
Common stock, $0.01 par value, one billion shares authorized, 302.7 million (268.4 million in 2014) issued $ 3.0 $ 2.7
Paid-in capital 8,195.3 4,330.7
Retained earnings 8,347.7 8,362.1
Accumulated other comprehensive (loss) income (329.0) 38.1
Treasury stock, 100.0 million shares (98.7 million shares in 2014) (6,329.1) (6,183.7)
Total Zimmer Biomet Holdings, Inc. stockholders' equity 9,887.9 6,549.9
Noncontrolling interest 1.5 1.8
Total Stockholders' Equity 9,889.4 6,551.7
Total Liabilities and Stockholders' Equity $ 27,219.5 $ 9,658.0